NASDAQ
Kezar Life Sciences, Inc. (KZR) has a fcf yield of -112.52% as of Friday, May 29, 2026. This represents a 2620.37% decrease compared to its 12-month average of -4.14%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.